5-MeO-MiPT

What is 5-MeO-MiPT?

5-MeO-MiPT, commonly known as Moxy, is a synthetic psychedelic tryptamine. Its chemical name is 5-methoxy-N-methyl-N-isopropyltryptamine. It is structurally related to 5-MeO-DMT, but one of the methyl groups on the terminal nitrogen is replaced by an isopropyl group. This change affects its receptor interactions and metabolic profile, and user reports often describe a combination of stimulation, sensory enhancement and physical effects.

Chemistry and early reports

5-MeO-MiPT appeared on the research-chemical market in the 2000s and became known through online reports under the name Moxy. It is one of several 5-methoxy tryptamines in which the substituents on the terminal nitrogen have been varied. The shared prefix does not establish that 5-MeO-MiPT is shorter-acting or weaker than 5-MeO-DMT; the structural differences can affect its pharmacology.

Receptor pharmacology

Rickli and colleagues examined 5-MeO-MiPT in a 2016 study of novel tryptamines and classic hallucinogens. The compound interacted with 5-HT2A receptors and acted as a partial or full agonist in functional assays. The study also measured interactions with other monoamine receptors and transporters, showing that its pharmacology is not limited to one serotonin receptor. These results provide a direct experimental basis for its classification as a serotonergic psychedelic, although they do not predict the subjective experience in full. See “Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens”.

Metabolism and a documented intoxication case

5-MeO-MiPT has been examined in human liver microsomes and in authentic case samples. Grafinger and colleagues identified several metabolic pathways, including O-demethylation, N-demethylation, hydroxylation and N-oxide formation. The study also described an intoxication case involving a 32-year-old man who was found agitated and behaving aggressively in public. Blood and urine samples were analysed, and the investigators identified the parent compound and several metabolites.

The case demonstrates that 5-MeO-MiPT can be detected in biological samples and provides reference information for forensic analysis. It does not establish that every episode of agitation or unusual behaviour after exposure will have the same cause or course. The research is described in “Study of the in vitro and in vivo metabolism of the tryptamine 5-MeO-MiPT using human liver microsomes and real case samples”.

Subjective effects

Descriptions collected by PsychonautWiki and summarized in toxicological reviews often emphasize the physical and sensory aspects of Moxy. Users describe stimulation, tactile enhancement and a heightened response to music, alongside visual changes that may be less elaborate than those associated with some other psychedelics. The reports are not uniform, and some include anxiety, nausea or confusion.

Physical and perceptual effectsCognitive and emotional effects
  • Stimulation: increased energy and wakefulness are frequently described.
  • Tactile enhancement: touch and bodily sensations may become unusually prominent.
  • Visual changes: colour enhancement and mild to moderate visual distortions are reported.
  • Physical euphoria: some users describe a warm or pleasurable body sensation.
  • Discomfort: nausea, sweating, jaw tension and restlessness also appear in reports.
  • Mood elevation: euphoria, laughter and increased appreciation of music are described.
  • Sociability: some accounts mention increased talkativeness or a desire for social interaction.
  • Altered perception: attention, time perception and the sense of the surrounding environment may change.
  • Anxiety and confusion: these can occur, particularly when stimulation or sensory intensity becomes uncomfortable.

A 2020 review of psychoactive tryptamines summarized reported oral effects as lasting several hours, with a shorter course often described after inhalation. Such duration estimates are based largely on user reports and case literature, not controlled pharmacokinetic trials. The same review discusses nausea, anxiety, confusion and paranoia among reported adverse effects. See “Toxicology and Analysis of Psychoactive Tryptamines”.

Interpretation and safety evidence

The receptor and metabolism studies provide a clearer scientific picture of 5-MeO-MiPT than is available for many newer tryptamines. They do not, however, establish a complete safety profile. The clinical case literature is limited, and there is no large controlled human study defining its pharmacokinetics, long-term effects or interactions with other psychoactive substances.

5-MeO-MiPT Products

5-MeO-MiPT pellets

5-MeO-MiPT pellets

Price range: $315.00 through $1,050.00
Select options
5-MeO-MiPT freebase

5-MeO-MiPT freebase

Price range: $389.00 through $2,079.00
Select options
5-MeO-MiPT HCL

5-MeO-MiPT HCL

Price range: $368.00 through $2,048.00
Select options